Login to Your Account



Abuse Deterrence Goes OTC

Acura Asks Pharmacists to Join Fight Against Meth

By Brian Orelli
BioWorld Insight Contributing Writer

Monday, March 11, 2013

Acura Pharmaceuticals Inc. recently launched Nexafed, its version of pseudoephedrine that uses the biotech's abuse-deterrent technology to help disrupt the drug's conversion to methamphetamine. Acura is focusing its marketing message for the over-the-counter decongestant on pharmacists.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription